Lizl Lasky, DO
Neurology · Coeur D Alene, IDNPI 1184002966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $776 and has fallen 95.8% since, to $33 in 2024. That places this record below the midpoint for neurology clinicians in ID, where the typical reported total is $1,243.
Across 17 payments — averaging $73.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$297
- AstraZeneca$272
- Sanofi$227
- EMD Serono, Inc.$140
- Greenwich Biosciences, Inc.$128
- Teva Pharmaceuticals USA, Inc.$72
- plus $107 from 4 others
What the payments were for
- Food & beverage$1,22999%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 3 | $297 |
| AstraZeneca | 3 | $272 |
| Sanofi | 2 | $227 |
| EMD Serono, Inc. | 2 | $140 |
| Greenwich Biosciences, Inc. | 1 | $128 |
| Teva Pharmaceuticals USA, Inc. | 1 | $72 |
| AbbVie | 2 | $55 |
| Eisai Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| Neurelis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,243 in reported general payments places this provider in the 50th percentile of 59 neurology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 12 | $8,528 |
| Mycophenolate Mofetil | 11 | $3,662 |
| Lacosamide | 27 | $3,313 |
| Pyridostigmine Bromide | 20 | $1,641 |
| Carbamazepine ErCarbamazepine | 17 | $1,543 |
| Levetiracetam ErLevetiracetam | 22 | $1,380 |
| Levetiracetam | 39 | $1,154 |
| Primidone | 27 | $777 |
| Gabapentin | 32 | $681 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 21 | $675 |
| Lamotrigine | 56 | $578 |
| Divalproex Sodium | 22 | $453 |
| Topiramate | 34 | $389 |
| Pregabalin | 21 | $383 |
| Baclofen | 13 | $283 |
Paid to pharmacies, not to this prescriber.
Other neurology in Coeur D Alene
- Nina BozinovCoeur D Alene$76K
- Angela PanaCoeur D Alene$37K
- Cliff HamptonCoeur D Alene$1K
- Charles BrittCoeur D Alene$909
- David SchreiberCoeur D Alene$166
- Michah BrasseurCoeur D Alene$146
- Matthew WomeldorffCoeur D Alene$70
- Bradford TalcottIdaho Falls$252K
- Lawrence GreenNampa$193K
- Stephen VincentIdaho Falls$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.